GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Ending Cash Position

SOFIVA GENOMICS Co (ROCO:6615) Ending Cash Position : NT$93.1 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Ending Cash Position?

SOFIVA GENOMICS Co's Ending Cash Position for the quarter that ended in Mar. 2025 was NT$93.1 Mil.

SOFIVA GENOMICS Co's quarterly Ending Cash Position increased from Sep. 2024 (NT$102.1 Mil) to Dec. 2024 (NT$112.1 Mil) but then declined from Dec. 2024 (NT$112.1 Mil) to Mar. 2025 (NT$93.1 Mil).

SOFIVA GENOMICS Co's annual Ending Cash Position declined from Dec. 2022 (NT$119.8 Mil) to Dec. 2023 (NT$96.8 Mil) but then increased from Dec. 2023 (NT$96.8 Mil) to Dec. 2024 (NT$112.1 Mil).

SOFIVA GENOMICS Co Ending Cash Position Historical Data

The historical data trend for SOFIVA GENOMICS Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Ending Cash Position Chart

SOFIVA GENOMICS Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.85 214.99 119.81 96.81 112.08

SOFIVA GENOMICS Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.05 87.22 102.08 112.08 93.08

SOFIVA GENOMICS Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

SOFIVA GENOMICS Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=96.806+15.273
=112.1

SOFIVA GENOMICS Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=112.079+-18.999
=93.1

SOFIVA GENOMICS Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

SOFIVA GENOMICS Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Ending Cash Position
Comparable Companies
ROCO:6939 ROCO:7595 ROCO:6661 ROCO:6847 TPE:6645 ROCO:4160 ROCO:4153 ROCO:1784 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
N/A
Address
No. 66-1, Sec. 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
Website
https://www.sofivagenomics.com.tw
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, pre-natal and neonatal genetic testing and medical testing and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines